Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (50)

2024

  1. Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas

    Pharmaceutics, Vol. 16, Núm. 2

  3. Thermal characterization, polymorphism, and stability evaluation of Se-NSAID derivatives with potent anticancer activity

    Journal of Thermal Analysis and Calorimetry, Vol. 149, Núm. 3, pp. 1015-1028

  4. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties

    European Journal of Medicinal Chemistry, Vol. 268

2023

  1. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  2. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

    Antioxidants, Vol. 12, Núm. 9

  3. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

  4. Novel Acylselenourea Derivatives: Dual Molecules with Anticancer and Radical Scavenging Activity

    Antioxidants, Vol. 12, Núm. 7

  5. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

2022

  1. Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer

    European Journal of Medicinal Chemistry, Vol. 244

  2. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  3. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  4. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects

    European Journal of Medicinal Chemistry, Vol. 244

  5. New Experimental Conditions for Diels–Alder and Friedel-Crafts Alquilation Reactions with Thiophene: A New Seleno-cyanate with Potent Activity Against Cancer

    Molecules, Vol. 27, Núm. 3

  6. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

  7. Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity

    Pharmaceutics, Vol. 14, Núm. 2

  8. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential

    Molecules, Vol. 27, Núm. 21

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5